Nancy Lin
Harvard University
H-index: 87
North America-United States
Top articles of Nancy Lin
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial | Nature Communications | Jorge Gómez Tejeda Zañudo Romualdo Barroso-Sousa Esha Jain Qingchun Jin Tianyu Li | 2024/3/19 |
Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer | Cancer Research | Heather A Parsons Conor Messer Katheryn Santos Brian P Danysh Melissa E Hughes | 2023/4/4 |
Abstract PO2-20-01: The STOP-HER2 Trial: A Phase 2 Study of Stopping Trastuzumab-Outcomes in Patients with HER2+ Metastatic Breast Cancer (TBCRC 062) | Cancer Research | Heather Parsons Kathryn Ruddy Stefania Morganti Karen Smith Victoria Attaya | 2024/5/2 |
Abstract PS11-01: Brain metastases in metastatic breast cancer: prevalence per line of treatment and cumulative incidence in a cohort of 18075 real-world patients | Cancer Research | Sarah Sammons Jose Leone Thibaut Sanglier Peter Lambert Filippo Montemurro | 2024/5/2 |
Abstract PS13-09: Molecular and immunological landscape of sex-based differences in breast cancer: a distinct disease in men | Cancer Research | Dario Trapani Sachin Deshmukh Sharon Wu Joanne Xiu Phil Walker | 2024/5/2 |
Abstract PS08-09: Impact of HER2 expression dynamics on the real-world activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE) | Cancer Research | Paolo Tarantino Melissa Hughes Ross Kusmick Laura Alder Alyssa Pereslete | 2024/5/2 |
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer | Journal of Clinical Oncology | Stefania Morganti Christopher J Gibson Qingchun Jin Katheryn Santos Ashka Patel | 2024/1/8 |
Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade | Breast Cancer Research and Treatment | Jorge Avila Julieta Leone Carlos T Vallejo Nancy U Lin José P Leone | 2024/3/7 |
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer | NPJ Breast Cancer | Stefania Morganti Qingchun Jin Julie Vincuilla Ryan Buehler Sean Ryan | 2024/4/16 |
Abstract PO2-04-01: Predictors of exceptional response to first line HER2-targeted therapy for metastatic breast cancer | Cancer Research | Stefania Morganti Tianyu Li Katheryn Santos Melissa Hughes Nolan Priedigkeit | 2024/5/2 |
Abstract PO3-03-05: Clinical outcomes in early-stage TNBC according to HER2-low status | Cancer Research | Ana Garrido-Castro Danielle Brandes Zakon Qingchun Jin Michael Grimm Akshara Singareeka Raghavendra | 2024/5/2 |
Abstract PO4-04-12: A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib or alpelisib in patients with estrogen receptor-positive, human epidermal growth … | Cancer Research | Virginia Borges Carlos Alemany Nancy Lin Sara Nunnery Cynthia Ma | 2024/5/2 |
Abstract PO2-11-02: Incidence, treatment patterns and outcomes of breast cancer during the first year of the COVID pandemic: A population-based study | Cancer Research | Jose Leone Julieta Leone Michael Hassett Rachel Freedman Jorge Avila | 2024/5/2 |
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer | NPJ Breast Cancer | Jennifer L Guerriero Jia-Ren Lin Ricardo G Pastorello Ziming Du Yu-An Chen | 2024/1/2 |
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer | JAMA oncology | Julieta Leone Michael J Hassett Rachel A Freedman Sara M Tolaney Noah Graham | 2024/2/29 |
Abstract CT074: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis from estrogen receptor … | Cancer Research | Erika Hamilton Sung-Bae Kim Nancy U Lin Ahmad Awada Eva Ciruelos Gil | 2024/4/5 |
Abstract PO2-10-07: Patterns of presentation, treatment and survival for older patients with metastatic breast cancer (MBC): results from a large prospective registry | Cancer Research | Melissa Hughes Alyssa Patterson Alexandra Newman Amanda Higgins Gregory Kirkner | 2024/5/2 |
Abstract PO2-05-05: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen … | Cancer Research | Nuhad Ibrahim Sung-Bae Kim Nancy Lin Ahmad Awada Eva Ciruelos Gil | 2024/5/2 |
Abstract PS06-07: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform | Cancer Research | Heather Parsons Sylvan Baca Anthony D'Ippolito Hyun-Hwan Jeong Kalie Smith | 2024/5/2 |
Abstract PO1-03-08: Association of patient-reported triple-negative breast cancer (TNBC) knowledge with clinical trial participation | Cancer Research | Megan Tesch Noah Graham Sean Ryan Melissa Hughes Eileen Wrabel | 2024/5/2 |
Co-Authors
